Skip to main content
. 2016 Jun 24;7(3):89–94. doi: 10.14740/cr469w

Table 1. Patient and Control Group Clinical Data.

Patients with PAF Control group P values
Number of participants in the group 51 52 0.89
Mean age (years) 59.84 ± 1.60 59.50 ± 1.46 0.87
Men/women 26/25 26/26 1/0.93
Accompanying diseases
  Hypertension 37 (72.54%) 34 (65.38%) 0.44
  Diabetes mellitus type 2 3 (5.88%) 2 (3.84%) 0.62
  Chronic ulcer disease 2 (3.92%) 0 0.15
  Status after hysterectomy 2 (3.92%) 1 (1.92%) 0.54
  Benign prostatic hyperthrophy 1 (1.96%) 0 0.32
Dyslipidemia 4 (7.84%) 3 (5.77%) 0.69
Medicaments for hypertension and dyslipidemia
  Beta blockers 19 (37.25%) 17 (32.69%) 0.62
  ACE inhibitors 15 (29.41%) 14 (26.92%) 0.78
  Sartans 11 (21.57%) 9 (17.31%) 0.58
  Statins 4 (7.84%) 3 (5.77%) 0.69
Deleterious habits
  Smoking* 8 (15.69%) 7 (13.46%) 0.75
  Alcohol intake** 7 (13.72%) 6 (11.53%) 0.74
BMI (kg/m2) 23.85 ± 0.46 24.95 ± 0.45 0.09

*Less than 0.5 pack (10 cigarettes)/week. Hospitalized patients had not smoked at least 24 h prior to the arrhythmia. Data from controls were taken after a 48-h non-smoking period. **No more than 2 drinks/week. Hospitalized patients had at least a 48-h period without alcohol prior to the arrhythmia. Data from controls were taken after a 48-h period without alcohol.